OS-08 Three Adverse Drug Interactions That Every Endodontist Should Know About
CE Hours: 1.0
Description: This presentation will focus on two areas. 1) Serious adverse drug interactions that may occur in the Endodontic Patient because of drugs that he/she prescribes or administers and 2) Serious adverse drug interactions that may occur in the endodontist himself/herself because of drugs that they are taking for various medical conditions. The three serious drug interactions that may adversely affect the dental patient include; 1) the ability of the antimicrobials metronidazole and fluconazole to inhibit the metabolism of warfarin by blocking cytochrome P-450 2C9 (CYP-2C9), the major metabolic pathway of warfarin, resulting in dramatic increases in patients' international normalized ratios (INRs) and potentially fatal bleeding. 2) The ability of ibuprofen or naproxen sodium to inhibit the renal excretion of the major bipolar disorder drug lithium resulting in tremors, seizures and renal toxicity. 3) The ability of propranolol and other nonselective beta-adrenergic blocking agents to inhibit the vasodilatory effect of epinephrine in dental local anesthetic solutions, leading to severe hypertensive reactions and a concomitant reflex bradycardia. Interactions relevant to the health of dentists themselves include the ability of grapefruit juice/grapefruit to elevate blood levels of statin cholesterol lowering drugs, increasing the risk of myalgia, rhabdomyolysis and acute renal failure. It is important for clinicians to understand the theoretical basis behind these often-predictable interactions, and comprehend the evidenced-based-science that supports their existence.
Learning Objectives:
- Discuss the pharmacological mechanism behind the potentially lethal metronidazole or fluconazole/warfarin interaction.
- Discuss the rationale of why recommending ibuprofen (Advil®) and naproxen sodium (Aleve®) for pain control is a bad idea in a bipolar disorder patient taking lithium (Eskalith®).
- Identify which class of anti-hypertensive drugs where high doses but therapeutic doses of local anesthetic plus epinephrine is most likely to cause a a pressor response with a reflex bradycardia.
Key:
Elliot V. Hersh, D.MD, M.S., Ph.D
Dr. Elliot V. Hersh is currently a professor of pharmacology/oral surgery at the University of Pennsylvania School of Dental Medicine. He received his D.M.D. degree from New Jersey Dental School UMDNJ in 1981 and his M.S. and Ph.D. degrees from UMDNJ Graduate School of Biomedical Sciences in 1983 and 1988 respectively. Since arriving at the University of Pennsylvania in 1988, Dr. Hersh has won the Dental School's Excellence in the Teaching of Basic Science Award 24 different times and was also presented with a University Lindback Award in 1993, the highest teaching honor in the entire university. He has published more than 200 scientific articles, abstracts and book chapters in the areas of dental pharmacology, drug interactions, analgesics and local anesthetics. His scholarly and research contributions in the areas of local anesthesia and pain control were recognized by the International Association of Dental Research in 2007 when he was presented with the Distinguished Scientist Award in Pharmacology, Therapeutics and Toxicology. He is currently collaborating with Dr Katherine Theken at PENN in trying to identify presurgical biomarkers that may predict the analgesic response to NSAIDs. "While the research accolades are nice, the most important thing I do is sharing this knowledge with my students and other dental professionals."
Disclosure(s): NIH/NIDCR: Grant/Research Support (Ongoing)